Cite
Lee JJ, Sholl LM, Lindeman NI, et al. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics. 2015;7:59doi: 10.1186/s13148-015-0091-3.
Lee, J. J., Sholl, L. M., Lindeman, N. I., Granter, S. R., Laga, A. C., Shivdasani, P., Chin, G., Luke, J. J., Ott, P. A., Hodi, F. S., Mihm, M. C., Lin, J. Y., Werchniak, A. E., Haynes, H. A., Bailey, N., Liu, R., Murphy, G. F., & Lian, C. G. (2015). Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clinical epigenetics, 759. https://doi.org/10.1186/s13148-015-0091-3
Lee, Jonathan J, et al. "Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas." Clinical epigenetics vol. 7 (2015): 59. doi: https://doi.org/10.1186/s13148-015-0091-3
Lee JJ, Sholl LM, Lindeman NI, Granter SR, Laga AC, Shivdasani P, Chin G, Luke JJ, Ott PA, Hodi FS, Mihm MC, Lin JY, Werchniak AE, Haynes HA, Bailey N, Liu R, Murphy GF, Lian CG. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics. 2015 Jun 09;7:59. doi: 10.1186/s13148-015-0091-3. eCollection 2015. PMID: 26221190; PMCID: PMC4517542.
Copy
Download .nbib